Page last updated: 2024-08-16

ribavirin and glucagon-like peptide 1

ribavirin has been researched along with glucagon-like peptide 1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Clément, AC; Cooper, CL; Crawley, AM; Doyle, MA; Fadzeyeva, E; Fullerton, MD; Hanson, AA; Jacobs, RL; Jeraj, N; Kim, KH; Locatelli, CA; Lorenzen-Schmidt, I; Morrow, NM; Mulvihill, EE; Nguyen, MA; Nunes, JR; O'Dwyer, C; Pulente, SM; Seymour, R; Travis, N; Trzaskalski, NA; van der Veen, JN; Vulesevic, B1

Other Studies

1 other study(ies) available for ribavirin and glucagon-like peptide 1

ArticleYear
Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression.
    JCI insight, 2023, Jan-24, Volume: 8, Issue:2

    Topics: Animals; Dipeptidyl Peptidase 4; Endothelial Cells; Glucagon-Like Peptide 1; Glucose; Hepatitis C; Hepatocytes; Mice; Non-alcoholic Fatty Liver Disease; Ribavirin

2023